CXADRP1, CXADR pseudogene 1, 653108

N. diseases: 272; N. variants: 0
Disease: Lymphoid leukemia ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023448
Disease: Lymphoid leukemia
Lymphoid leukemia 		0.050 Biomarker disease BEFREE Anti-CD19-CAR is currently clinically available as one of the therapeutic modalities for refractory acute B-cell-typed lymphoblastic leukemia (B-ALL) patients. 30539476 2019
CUI: C0023448
Disease: Lymphoid leukemia
Lymphoid leukemia 		0.050 Biomarker disease BEFREE Chimeric antigen receptor engineered T (CAR-T) cells have exhibited excellent therapeutic effect on lymphocytic leukemia in recent years. 30381966 2019
CUI: C0023448
Disease: Lymphoid leukemia
Lymphoid leukemia 		0.050 GeneticVariation disease BEFREE FCM was performed on samples from 9 patients with B-ALL treated with CAR-T. 28888074 2018
CUI: C0023448
Disease: Lymphoid leukemia
Lymphoid leukemia 		0.050 Biomarker disease BEFREE Chimeric antigen receptor-engineered T (CAR-T) cells have extraordinary effect in treating lymphoblastic leukemia. 29716633 2018
CUI: C0023448
Disease: Lymphoid leukemia
Lymphoid leukemia 		0.050 Biomarker disease BEFREE A pediatric patient diagnosed initially with B-lymphoblastic leukemia (B-ALL) relapsed with lineage switch to acute myeloid leukemia (AML) after chimeric antigen receptor T-cell (CAR-T) therapy and hematopoietic stem cell transplant. 29797659 2018